Table 1.
Clinical characteristics of eligible patients.
| Characteristics | Case (n=105, %) |
|---|---|
| Mean age (years) | 54.16±10.79 |
| Sex | |
| Male | 69 (65.71%) |
| Female | 36 (34.29%) |
| Tumor location | |
| Right side | 50 (47.62%) |
| Left side | 55 (52.38%) |
| Differentiation | |
| Moderate | 64 (60.95%) |
| Poor | 41 (39.05%) |
| Smoker | |
| No | 55 (52.38%) |
| Yes | 50 (47.62%) |
| T stages | |
| T1–T2 | 42 (40%) |
| T3–T4 | 63 (60%) |
| Chemotherapy strategies | |
| 5-FU+levamisol | 41 (39.05%) |
| 5-FU+leucovorin | 52 (49.52%) |
| Capecitabine | 12 (11.43%) |
| Chemotherapy response | |
| CR | 18 (17.14%) |
| PR | 38 (36.19%) |
| SD | 39 (37.14%) |
| PD | 9 (8.57%) |
| CR+PR | 56 (53.33%) |